Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker? Thuring J, Kuhl CK, Barabasch A, Hitpass L, et al. PLoS One 2020;15:e0230553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thuring J, Kuhl CK, Barabasch A, Hitpass L, et al. Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker? PLoS One 2020;15:e0230553.
PMID: 32231380